Company profile: Sepax Technologies
1.1 - Company Overview
Company description
- Provider of chromatography columns and resins for biomolecule separation and analysis, including ion exchange (Proteomix IEX), hydrophobic interaction (Proteomix HIC Butyl), size exclusion for ADCs and other biomolecules (Monomix MC SEC resins; Zenix-C SEC), reverse phase for DAR analysis (Proteomix RP-1000), and weak cation exchange for monoclonal antibodies (Antibodix WCX), plus method development services.
Products and services
- Zenix-C SEC: Analytical-grade columns for size exclusion analysis of ADCs, separating aggregate, monomer, fragment, and free drug species within chromatographic workflows
- Proteomix RP-1000: Research-grade columns engineered for Drug to Antibody Ratio (DAR) analysis, enabling targeted characterization of ADC conjugation levels during analytical chromatography
- Monomix MC SEC Resins: Chromatography-grade stable resins for size exclusion chromatography, offering broad pH tolerance and compatibility with various solvents and buffers for versatile separations
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Sepax Technologies
BAC
HQ: United States
Website
- Description: Provider of affinity purification products and services for the biopharmaceutical market, with CaptureSelect products used from drug discovery to manufacturing of biopharmaceuticals, based on a proprietary platform integrating affinity ligand discovery, manufacturing and immobilization of single domain antibodies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BAC company profile →
Biotix
HQ: United States
Website
- Description: Provider of laboratory consumables and liquid handling solutions, including pipette tips (xTIP4, uTIP, aTIP), the Ergonomix manual pipetting system with light ejection, assay and deep well plates made from medical-grade virgin polypropylene, reagent reservoirs certified free of DNase/RNase/endotoxins, OEM custom consumables design and manufacturing, and Defender face shields for splash protection.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Biotix company profile →
Affymetrix
HQ: United States
Website
- Description: Provider of innovative technologies enabling multiplex and parallel analysis of biological systems at the cell, protein, and gene level, facilitating rapid translation of results into biology. Offerings include GeneChip microarrays for gene expression and genetic variation analysis, GeneTitan for high-throughput microarray processing, Axiom genotyping solutions, and CytoScan cytogenetic microarrays for detecting chromosomal abnormalities.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Affymetrix company profile →
SeqLL
HQ: United States
Website
- Description: Provider of molecule sequencing technology for research and healthcare communities.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full SeqLL company profile →
Nanosphere
HQ: United States
Website
- Description: Provider of a nanotechnology-based molecular diagnostics platform and clinical tests for genomic and protein testing and analysis. Instruments use microfluidics to pull DNA and proteins, delivering results in hours rather than days or weeks, with sensitivity two to three times higher than common hospital lab tests and much simpler.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nanosphere company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Sepax Technologies
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Sepax Technologies
2.2 - Growth funds investing in similar companies to Sepax Technologies
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Sepax Technologies
4.2 - Public trading comparable groups for Sepax Technologies
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →